Endeavor

FDA Approval Brings New Standard of Care for Endometrial Cancer

Combination of immunotherapy and chemotherapy becomes new first line of defense

FDA Approves New Immunotherapy for Rare Blood Cancer

Lymphir offers a new option for patients with hard-to-treat cutaneous T-cell lymphoma

FDA Approves New Gene Therapy for Rare Soft Tissue Cancer

First-of-its-kind treatment offers new hope for adults with advanced synovial sarcoma

For These 2 Team Members, the Hope Behind Cell Therapies Is Personal

Alexander Dojcinovski and Jasmine Cherry are both now cancer free and working to cure others

FDA Approves New Immunotherapy for Follicular Lymphoma

Epcoritamab brings hope and improved outcomes for patients with limited options

What Is Immunotherapy?

Harnessing the immune system to attack cancer gives patients new treatment options

Evaluating the Microbiome in Patients with Triple Negative Breast Cancer

Moffitt-led Pilot study looked at gut microbiome as biomarker for treatment response

The Long Journey in Search of a Cure

With one TIL therapy approved by the FDA, doctors push to optimize the treatment. Michelle Shannon is living for the next breakthrough.

Study Explores mRNA Vaccine Combo Therapy for Advanced Non-Small Cell Lung Cancer

Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy